Commonwealth Equity Services, LLC Teva Pharmaceutical Industries LTD Transaction History

Commonwealth Equity Services, LLC

  • $66 Billion
  • Q3 2024

A detailed history of Commonwealth Equity Services, LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 173,596 shares of TEVA stock, worth $3.95 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
173,596
Previous 162,770 6.65%
Holding current value
$3.95 Million
Previous $2.65 Million 18.26%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024
BUY
$15.81 - $18.96 $171,159 - $205,260
10,826 Added 6.65%
173,596 $3.13 Million
Q2 2024

Jul 31, 2024
SELL
$12.78 - $17.4 $1.37 Million - $1.87 Million
-107,533 Reduced 39.78%
162,770 $2.65 Million
Q1 2024

Apr 29, 2024
SELL
$10.67 - $14.43 $406,228 - $549,378
-38,072 Reduced 12.35%
270,303 $3.81 Million
Q4 2023

Feb 06, 2024
BUY
$8.12 - $10.63 $429,531 - $562,305
52,898 Added 20.71%
308,375 $3.22 Million
Q3 2023

Oct 23, 2023
BUY
$7.48 - $10.7 $94,150 - $134,680
12,587 Added 5.18%
255,477 $2.61 Million
Q2 2023

Aug 10, 2023
BUY
$7.2 - $9.47 $522,633 - $687,408
72,588 Added 42.62%
242,890 $1.83 Million
Q1 2023

May 11, 2023
BUY
$8.36 - $11.37 $418,050 - $568,568
50,006 Added 41.57%
170,302 $1.51 Million
Q4 2022

Feb 07, 2023
BUY
$7.95 - $9.48 $2,353 - $2,806
296 Added 0.25%
120,296 $1.1 Million
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $53,610 - $93,389
-7,815 Reduced 6.11%
120,000 $968,000
Q2 2022

Jul 19, 2022
SELL
$7.38 - $10.4 $13,874 - $19,552
-1,880 Reduced 1.45%
127,815 $961,000
Q1 2022

May 04, 2022
SELL
$7.33 - $9.39 $108,366 - $138,821
-14,784 Reduced 10.23%
129,695 $1.22 Million
Q4 2021

Jan 31, 2022
SELL
$7.9 - $10.19 $179,938 - $232,097
-22,777 Reduced 13.62%
144,479 $1.16 Million
Q3 2021

Oct 29, 2021
SELL
$8.38 - $10.18 $18,477 - $22,446
-2,205 Reduced 1.3%
167,256 $1.63 Million
Q2 2021

Aug 11, 2021
SELL
$9.9 - $11.56 $133,125 - $155,447
-13,447 Reduced 7.35%
169,461 $1.68 Million
Q1 2021

May 04, 2021
BUY
$10.34 - $12.81 $148,037 - $183,400
14,317 Added 8.49%
182,908 $2.11 Million
Q4 2020

Feb 11, 2021
BUY
$8.61 - $11.04 $80,770 - $103,566
9,381 Added 5.89%
168,591 $1.63 Million
Q3 2020

Nov 05, 2020
SELL
$8.57 - $12.69 $221,380 - $327,808
-25,832 Reduced 13.96%
159,210 $1.43 Million
Q2 2020

Aug 12, 2020
SELL
$8.12 - $13.12 $24,075 - $38,900
-2,965 Reduced 1.58%
185,042 $2.28 Million
Q1 2020

May 11, 2020
BUY
$6.69 - $13.45 $170,113 - $342,006
25,428 Added 15.64%
188,007 $1.69 Million
Q4 2019

Feb 05, 2020
SELL
$6.53 - $10.72 $45,455 - $74,621
-6,961 Reduced 4.11%
162,579 $1.59 Million
Q3 2019

Oct 30, 2019
BUY
$6.16 - $9.6 $57,053 - $88,915
9,262 Added 5.78%
169,540 $1.17 Million
Q2 2019

Jul 19, 2019
BUY
$8.12 - $15.72 $41,152 - $79,668
5,068 Added 3.27%
160,278 $1.48 Million
Q1 2019

May 13, 2019
SELL
$15.58 - $20.01 $89,024 - $114,337
-5,714 Reduced 3.55%
155,210 $2.43 Million
Q4 2018

Feb 11, 2019
SELL
$14.59 - $23.84 $340,778 - $556,830
-23,357 Reduced 12.67%
160,924 $2.48 Million
Q3 2018

Nov 06, 2018
BUY
$21.06 - $25.65 $529,090 - $644,404
25,123 Added 15.78%
184,281 $3.97 Million
Q2 2018

Jul 31, 2018
SELL
$16.77 - $24.71 $105,382 - $155,277
-6,284 Reduced 3.8%
159,158 $3.87 Million
Q1 2018

May 14, 2018
BUY
$16.68 - $22.07 $19,599 - $25,932
1,175 Added 0.72%
165,442 $2.83 Million
Q4 2017

Feb 12, 2018
BUY
$11.23 - $19.1 $1.84 Million - $3.14 Million
164,267
164,267 $3.11 Million

Others Institutions Holding TEVA

# of Institutions
625
Shares Held
573M
Call Options Held
19.6M
Put Options Held
6.77M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.3B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email